Connect Conference & Show Floor Educational Sessions

View, browse and sort the list of Connect Conference sessions and show floor programming by pass type, track, and format. Please note, all Connect Conference delegates have access to CPhI Connect and InformEx Connect programming. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

To learn more about the Connect Conference program, click here.

All SessionsSpeakersMy Schedule
View Sessions As:
  • Haripada Maity Ph.D.Research AdvisorFormulation Development, CMC Development, Eli Lilly and Company

    Haripada Maity, Ph.D. is a Research Advisor in the Formulation Development Department, Lilly NJ, where he leads the Biophysical Group. He joined Lilly NJ in August 2007 and has about 25 years of research experience in the area of protein chemistry. His primary areas of research include protein formulation development, biophysical characterization including thermodynamic analysis of protein stability, comparability assessment, solubility measurements, protein folding/unfolding studies, hydrogen exchange monitored by NMR, chromatography, structure-function relationships, protein-ligand interactions, and protein-protein interactions. Haripada obtained his Ph.D. from Tata Institute of Fundamental Research, India in 1998. He performed his major postdoctoral research work in the Department of Biochemistry and Biophysics at the University of Pennsylvania School of Medicine, USA. Haripada was awarded the prestigious Extraordinary Effort Award of Lilly NJ twice both in 2008 and 2011. He was also awarded BHU Medal (Gold Medal) from Banaras Hindu University, India in 1991. At present, Haripada has already authored/co-authored twenty eight articles in scientific journals/Book. In addition, he has twenty three conference publications in the form of posters and abstracts. Haripada has presented multiple presentations on pharmaceutical research as an invited speaker including the role as chairperson and panelist. He is an Editorial Board Member of the journal "Current Pharmaceutical Biotechnology".